Strategy for Hepatitis B and C Virus Testing Campaigns Through Web Services and Digital Advertising in Japan: Nationwide Cross-Sectional Study With Correspondence Analysis.

From 2015 to 2022, a decreasing trend in acute-onset HBV and HCV hepatitis was reported, partially attributable to strengthened surveillance systems and, in the case of HCV, to remarkable advances in treatment with direct-acting antivirals, which have dramatically reduced the disease burden [ 5 ].

also in 47,180 other papers